UP!
 |
|
|
Type
|
Public |
|---|---|
| Industry | Biotechnology |
|
Key people
|
Ian Massey (CEO) Irving L. Weissman, M.D. (Founder) |
| Website | www.stemcellsinc.com |
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
They are being studied in early stage trials.
| 2016-06-24 | Lower Price Target | S&P Equity Research | $0.39 to $0.33 | |
| 2016-06-17 | Lower Price Target | S&P Equity Research | $0.42 to $0.35 | |
| 2016-05-31 | Downgrade | Maxim Group | Buy to Hold | |
| 2016-05-11 | Lower Price Target | S&P Equity Research | $3.59 to $2.99 | |
| 2016-05-10 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2016-04-27 | Lower Price Target | S&P Equity Research | $3.72 to $3.24 | |
| 2016-04-20 | Initiated Coverage | Rodman & Renshaw | Buy | $18.00 |
| 2016-04-19 | Reiterated Rating | Maxim Group | Buy | $36.00 |
| 2016-03-28 | Reiterated Rating | Chardan Capital | Buy | $12.00 to $6.00 |
| 2016-03-28 | Reiterated Rating | Maxim Group | Buy | $3.00 |
| 2016-01-19 | Reiterated Rating | Maxim Group | Buy | $3.00 |
| 2015-12-30 | Reiterated Rating | Chardan Capital | Buy | |
| 2015-12-30 | Lower Price Target | HC Wainwright | Buy | $25.20 to $18.00 |
| 2015-12-29 | Reiterated Rating | Maxim Group | Buy | |
| 2015-12-24 | Reiterated Rating | Chardan Capital | Buy | $1.55 to $1.00 |
| 2015-12-23 | Reiterated Rating | Maxim Group | Buy | $3.00 |
| 2015-11-24 | Reiterated Rating | HC Wainwright | Buy | $2.10 |
| 2015-11-19 | Reiterated Rating | Chardan Capital | Buy | $1.55 |
| 2015-11-18 | Reiterated Rating | Maxim Group | Buy | $5.00 |
| 2015-09-02 | Reiterated Rating | RBC Capital | Buy | |
| 2015-09-02 | Reiterated Rating | Royal Bank Of Canada | Buy | |
| 2015-08-10 | Reiterated Rating | Cantor Fitzgerald | Buy | $24.00 |
| 2015-07-21 | Reiterated Rating | Maxim Group | Buy | $5.00 |
| 2015-06-22 | Reiterated Rating | Cantor Fitzgerald | Buy | $2.00 |
| 2015-05-21 | Initiated Coverage | Cantor Fitzgerald | Buy | $2.00 |
| 2015-05-18 | Reiterated Rating | Maxim Group | Buy | $5.00 |
| 2015-05-18 | Initiated Coverage | HC Wainwright | Buy | $1.00 |
| 2015-05-11 | Lower Price Target | Chardan Capital | Buy | $2.25 to $1.55 |
| 2015-05-06 | Reiterated Rating | Ascendiant Capital Markets | Buy | $18.00 |
| 2015-01-26 | Initiated Coverage | Chardan Capital | Buy | $2.25 |
| 2014-12-22 | Set Price Target | Maxim Group | Buy | $5.00 |
| 2014-10-07 | Initiated Coverage | Maxim Group | Buy | |
| 2014-07-02 | Initiated Coverage | Brinson Patrick | Outperform | $84.00 |
| 2014-06-20 | Boost Price Target | Maxim Group | Buy | $2.50 to $5.00 |
| 2014-06-17 | Reiterated Rating | Chardan Capital | Positive | |
| 2014-05-19 | Reiterated Rating | Maxim Group | Positive | |
| 2014-04-17 | Edison Investment Research | Neutral | ||
| 2012-10-17 | Initiated | Ascendiant Capital Markets | Buy | $2.60 |
| 2016-06-24 | Lower Price Target | S&P Equity Research | $0.39 to $0.33 | |
| 2016-06-17 | Lower Price Target | S&P Equity Research | $0.42 to $0.35 | |
| 2016-05-31 | Downgrade | Maxim Group | Buy to Hold | |
| 2016-05-11 | Lower Price Target | S&P Equity Research | $3.59 to $2.99 | |
| 2016-05-10 | Reiterated Rating | Rodman & Renshaw | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In STEM 138 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 13.63M |
| BlackRock Inc. | 8.90M |
| Electron Capital Partners, LLC | 4.93M |
| STATE STREET CORP | 3.04M |
| ALKEON CAPITAL MANAGEMENT LLC | 2.54M |
| Encompass Capital Advisors LLC | 2.50M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.47M |
| CITADEL ADVISORS LLC | 1.65M |
| Invesco Ltd. | 1.64M |
| TORTOISE CAPITAL ADVISORS, L.L.C. | 1.49M |
| Nuveen Asset Management, LLC | 1.41M |
| BARCLAYS PLC | 1.31M |
| WELLINGTON MANAGEMENT CO LLP | 1.30M |
| HENDERSON GROUP PLC | 1.29M |
| NORTHERN TRUST CORP | 1.26M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Bornstein Yoseph | 6.60% (4530409) | STEM / |
| Lewkowicz Leon | 4.48% (3078214) | STEM / |
| Massey Ian J Chief Operating Officer | 3.47% (2378460) | STEM / |
| MCGLYNN MARTIN M President & CEO | 3.25% (2230297) | STEM / |
| SCHIFFMAN GREGORY T Chief Financial Officer | 2.33% (1599717) | DNDN / STEM / |
| Shoham Moshe | 2.27% (1558390) | STEM / |
| TSUKAMOTO ANN EVP, Research and Development | 1.03% (706511) | STEM / |
| WEISSMAN IRVING | 0.81% (558288) | STEM / |
| CRAIG STEWART SVP, Development & Operations | 0.59% (405981) | STEM / |
| Salinas Eliseo Oreste EVP and Head of R&D | 0.57% (390000) | STEM / |
| BJERKHOLT ERIC | 0.40% (273759) | SNSS / STEM / |
| Trounson Alan O | 0.30% (208253) | STEM / |
| SCHWARTZ JOHN J | 0.27% (188331) | STEM / |
| GREER R SCOTT | 0.21% (143841) | ASPX / INGN / NKTR / SIEN / STEM / VSAR / |
| LEVY RICARDO B | 0.17% (113691) | ACCL / STEM / |
| Stratton Kenneth Blair General Counsel | 0.06% (42273) | STEM / |
| Young Rodney KB CFO | 0.05% (36745) | STEM / |
| KOSHY GEORGE chief accounting officer | 0.04% (27308) | STEM / |
| PERLMUTTER ROGER M | 0.02% (13000) | MRK / STEM / |
UM